None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients who will give consent to take part in this study 2)Age group 18 to 60 years 3) American Society of Anesthesiologists (ASA) physicalstatus classI, II , III 4)Patients scheduled for elective surgery under GA
Exclusion criteria
Exclusion criteria: 1)Patient refusal for studyparticipation 2)ASA class IV and V 3)Allergic to etomidate and fentanyl 4)Presence of preexisting neurological orneuromuscular disorders 5)BMI >35 in females and >40 males (morbidly obese patients) 6)Patients with severe cardiovascular disease (NYHA 3, NYHA 4) 7)Psychiatric patients and patients onpsychotropic drugs 8) Parturient and breast-feeding mothers 9) Patients having adrenal pathology and septic patients (higher risk of adrenalsuppression
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| : To determine whether fentanyl would significantly reduce the dosage of etomidate required to abolish response to verbal commands or loss of response to noxious stimulusTimepoint: The response will be noted at the time end point of inductionwhich will take less than 10 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the relation between dosage of etomidate and end point of sedation during etomidate anesthesia with fentanyl at varying time intervals. Timepoint: 18 months | — |
Countries
India
Contacts
Jubilee Mission Medical College , Thrissur